GLOBAL LEADER IN CANNABINOID-DERIVED DRUG DISCOVERY & DEVELOPMENT
Tetra Bio-Pharma is focused on drug development programs in Inflammation, Pain, Ophthalmology and Oncology, aimed at bringing novel drugs and treatments to patients and their healthcare providers.
Tetra Bio-Pharma is focused on developing cannabinoid- derived medicines using supporting scientific validation and safety data required for inclusion into the pharmaceutical industry. The initial focus of Tetra Bio-Pharma is in the therapeutic areas of inflammation, pain, ophthalmology and oncology through a robust pipeline using multiple delivery systems.
Tetra Bio-Pharma is engaged in the development of an advanced and growing pipeline of biopharmaceuticals containing cannabinoid-derived medicines.
With patients at the core of its mission, Tetra Bio-Pharma is focused on providing new and improved healthcare solutions centered around patient outcomes comprising prevention, treatment and overall wellness.
RIGOROUS CLINICAL TRIALS
Clinical trials are an essential component of our drug discovery and development programs. Pioneering research initiatives is the cornerstone upon which the company is built.
PATENTED DELIVERY MECHANISMS
Tetra Bio-Pharma uses the most advanced medical devices, formulations and delivery systems in order to optimize patient care.
Quality is at the forefront of what we do. We are dedicated to providing exceptional pharmaceutical products to ensure efficacy and safety.
Staying Ahead Of
As the opioid epidemic affects millions in North America and continues to grow, there is an increasing demand for an alternative to opioids such as cannabis-based drugs that will replace the toxic and addictive side effect profile of opioids. Tetra Bio-Pharma is dedicated to conducting rigorous clinical trials with the goal of commercializing products on the foundation of scientific evidence.
Tetra Bio-Pharma (TSX: TBP) (OTCQB: TBPMF) is a Canadian-based company that has several subsidiaries engaged in the development of an advanced and growing pipeline of biopharmaceuticals, natural health and veterinary products containing cannabinoid-derived molecules and other medicinal plant-based elements.
With our deep technical expertise, innovative approach and proven track-record, we are truly invested in bringing novel drugs and treatments to patients and their healthcare providers.
Stay up-to-date with the latest news and information from Tetra Bio-Pharma, its subsidiaries and its partners by reading press releases, getting the latest updates on product development and finding out about upcoming events.
Register for email alerts to have the news you want delivered directly to your inbox and to be the first to know the latest announcements on how Tetra Bio-Pharma is reimagining the medical cannabis industry.